Showing results (1591-1600 of 1,697) with videos related to
Sort By:
Pageof 170
Journal of the Endocrine Society|March 9, 2026
Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST studyMontserrat Marques-Pamies, Laura Ricou, Joan Gil, et al.Science Translational Medicine|April 29, 2026
Adeno-associated virus gene therapy-mediated CCR5 blockade suppresses virus replication long term in SHIV-infected macaquesHelen L Wu, Gabriela M Webb, Sebastian P Fuchs, et al.British Journal of Cancer|March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association ConsortiumSuzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.Endocrine-Related Cancer|September 22, 2016
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegalyIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.International Journal of Epidemiology|December 7, 2017
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.International Journal of Epidemiology|April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studiesWeiva Sieh, Shannon Salvador, Valerie McGuire, et al.Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.British Journal of Cancer|August 18, 2017
History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief reportAlbina N Minlikeeva, Jo L Freudenheim, Rikki A Cannioto, et al.Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.Pageof 170